Aastrom Biosciences
Aastrom Biosciences reports on clinical trial status, fundraising
Published in Physician Law Weekly, October 11th, 2006
1) Completion of the accrual and treatment phase for all 36 patients enrolled in the U.S. phase I/II multicenter long bone fracture clinical trial.
2) Receipt of a local German human pharmaceuticals manufacturing license for the production of the company's TRC-based cell products for clinical use in compliance with German law and E.U. clinical trial directives. The newly licensed manufacturing facility was established as a collaboration at the Fraunhofer Institute for Interfacial Engineering and Biotechnology in Stuttgart, Germany,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-10-11)
More Articles from Physician Law Weekly
- AngioDynamics
AngioDynamics comments on judgment decision by court - Barr Pharmaceuticals
Barr files an amended tender offer for Pliva - Forensic Psychology Practice , U.K.
Treatment of sexual offenders with learning disabilities in the community is focus of review - Identa
Drug detection products made by IDenta earn acceptance of Chinese Federal Police - Indiana University, U.S.
Bioethics program in predictive health is established at Indiana University - Innogenetics
Jury finds Abbott infringed Innogenetics HCV patent - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
